Bay Area-based Theranos is coming under scrutiny after a Wall Street Journal article questioned the accuracy of the company's blood-testing technology. Since the article, plans for a $350 million partnership with Safeway fell through. Theranos, which is valued at $9 billion, hired a high-profile Supreme Court lawyer and is weighing a defamation lawsuit against the paper. We'll get the latest on Theranos and its recent interactions with the FDA and Capitol Hill.
Theranos Under Scrutiny After WSJ Criticism
This article is more than 7 years old.
(Andrew Burton/Getty Images)
Sponsored